{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:04:18Z","timestamp":1758816258734,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.transproceed.2020.08.029","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:42:55Z","timestamp":1599759775000},"page":"743-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation"],"prefix":"10.1016","volume":"53","author":[{"given":"Rafael","family":"Benito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquina","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Sahag\u00fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-5199","authenticated-orcid":false,"given":"Vicente","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.08.029_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.20126","article-title":"Human T-lymphotropic virus type II and neurological disease","volume":"56","author":"Araujo","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.transproceed.2020.08.029_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/clinids\/19.2.350-a","article-title":"Severe myopathy in an injection drug user coinfected with HIV-1 and HTLV-2","volume":"19","author":"Soriano","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2020.08.029_bib3","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1086\/522172","article-title":"HTLV-associated myelopathy\/tropical spastic paraparesis in an HIV-positive patient coinfected with HTLV-2 following initiation of antiretroviral therapy","volume":"45","author":"Toro","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2020.08.029_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.1970","article-title":"Human T-lymphotropic virus type 1 infection and solid organ transplantation","volume":"28","author":"Taylor","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.transproceed.2020.08.029_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMc1809779","article-title":"Risk of human T-cell leukemia virus type 1 infection in kidney transplantation","volume":"380","author":"Yamauchi","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2020.08.029_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00007890-200301150-00019","article-title":"Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type 1 from a single donor","volume":"75","author":"Toro","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.08.029_bib7","article-title":"Spanish HTLV Network. Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals","volume":"6","author":"Roc","year":"2019","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.transproceed.2020.08.029_bib8","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1182\/blood-2016-09-739433","article-title":"Global Virus Network\u2019s Task Force on HTLV-1. Screening transplant donors for HTLV-1 and -2","volume":"128","author":"Gallo","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2020.08.029_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6872-5_1","article-title":"Serological and molecular methods to study epidemiological aspects of human T-cell lymphotropic virus type 1 infection","volume":"1582","author":"Cassar","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.transproceed.2020.08.029_bib10","first-page":"233","article-title":"HTLV-1 infection is rising up in Spain whereas HTLV-2 is vanishing","volume":"21","author":"de Mendoza","year":"2019","journal-title":"AIDS Rev"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520326944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520326944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:36:45Z","timestamp":1758577005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134520326944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0041134520326944"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.08.029","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}